PUBLISHER: Grand View Research | PRODUCT CODE: 1750692
PUBLISHER: Grand View Research | PRODUCT CODE: 1750692
The global lactulose market size is anticipated to reach USD 732.0 million by 2030 and is anticipated to grow at a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for lactulose is rising prevalence of chronic constipation and liver-related disorders, particularly among the aging population. As a non-invasive and effective treatment, lactulose is widely prescribed for conditions like hepatic encephalopathy and irritable bowel syndrome.
The syrup/liquid segment dominated the market with a revenue share of 57.6% in 2024, during the forecast period. lactulose syrup plays a key role in managing hepatic encephalopathy, a serious complication of liver disease where patients experience high levels of ammonia in the blood. In such cases, lactulose is used to reduce ammonia absorption and improve mental status. Since these conditions require ongoing treatment, the syrup form is often used in long-term care and hospital protocols. The convenience of ready-to-use liquid packaging, availability across pharmacies, and frequent use in clinical prescriptions further contribute to its high volume consumption and market value.
The laxative segment dominated the market with a revenue share of 69.8% in 2024, during the forecast period. The segment in the lactulose market is essential as populations age particularly in countries like Japan, Germany, and the U.S.-the need for safe, effective laxatives has grown. Lactulose is also frequently recommended by physicians due to its dual benefit: not only does it relieve constipation, but it also improves gut flora, promoting overall digestive health. Available in various forms, including syrup, powder, and tablets, lactulose's flexibility in administration enhances its appeal
Asia Pacific dominated the market with a market share of 37.3% in 2024, during the forecast period. The Asia-Pacific region leads the lactulose market, driven by the rise in infant formula and functional drink markets, especially in China and South Korea, is boosting demand in the food & beverage segment. Moreover, local pharmaceutical manufacturing and a push for prebiotics in wellness trends are accelerating demand across Asia Pacific.
Some prominent players in the lactulose market include Fresenius Kabi, Orion Lifescience, Morinaga Milk Industry Co., Ltd., Abbott, Illovo, Biofac, Daiichi Sankyo, Inalco SpA, Casca Remedies, and Enrich Pharma.